Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The demand for polyvalent immunoglobulins in Italy.

Literature DB >> 24333313

The demand for polyvalent immunoglobulins in Italy.

Fabio Candura¹, Monica Lanzoni², Gabriele Calizzani¹, Samantha Profili¹, Stefania Vaglio³, Simonetta Pupella¹, Giancarlo M Liumbruno⁴, Giuliano Grazzini¹.

Abstract

Mesh：

Substances：

Year: 2013 PMID： 24333313 PMCID： PMC3853984 DOI： 10.2450/2013.009s

Source DB: PubMed Journal: Blood Transfus ISSN： 1723-2007 Impact factor: 3.443

× No keyword cloud information.

12 in total

Review 1. Intravenous immune globulins: an update for clinicians.

Authors: Irina Knezevic-Maramica; Margot S Kruskall
Journal: Transfusion Date: 2003-10 Impact factor: 3.157

2. Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease.

Authors: R C Dodel; Y Du; C Depboylu; H Hampel; L Frölich; A Haag; U Hemmeter; S Paulsen; S J Teipel; S Brettschneider; A Spottke; C Nölker; H J Möller; X Wei; M Farlow; N Sommer; W H Oertel
Journal: J Neurol Neurosurg Psychiatry Date: 2004-10 Impact factor: 10.154

Review 3. Use of intravenous immunoglobulin G (IVIG).

Authors: R John Looney; Jennifer Huggins
Journal: Best Pract Res Clin Haematol Date: 2006 Impact factor: 3.020

Review 4. Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.

Authors: Gabriele Calizzani; Samantha Profili; Fabio Candura; Monica Lanzoni; Stefania Vaglio; Livia Cannata; Liviana Catalano; Rosa Chianese; Giancarlo M Liumbruno; Giuliano Grazzini
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

Review 5. Public expenditure for plasma-derived and recombinant medicinal products in Italy.

Authors: Monica Lanzoni; Fabio Candura; Gabriele Calizzani; Claudia Biffoli; Giuliano Grazzini
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

Review 6. Polyvalent immunoglobulins: challenges and perspectives.

Authors: Isabella Quinti; Serelina Coluzzi; Federica Pulvirenti; Alessandro Prezzo; Gabriella Girelli
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

7. Recommendations for the use of albumin and immunoglobulins.

Authors: Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossettias
Journal: Blood Transfus Date: 2009-07 Impact factor: 3.443

8. Intravenous immunoglobulin for Alzheimer's disease.

Authors: Clive Holmes
Journal: Lancet Neurol Date: 2013-01-31 Impact factor: 44.182

9. Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial.

Authors: Richard Dodel; Axel Rominger; Peter Bartenstein; Frederik Barkhof; Kaj Blennow; Stefan Förster; Yaroslav Winter; Jan-Philipp Bach; Julius Popp; Judith Alferink; Jens Wiltfang; Katharina Buerger; Markus Otto; Piero Antuono; Michael Jacoby; Ralph Richter; James Stevens; Isaac Melamed; Jerome Goldstein; Stefan Haag; Stefan Wietek; Martin Farlow; Frank Jessen
Journal: Lancet Neurol Date: 2013-01-31 Impact factor: 44.182

Review 10. Modern plasma fractionation.

Authors: Thierry Burnouf
Journal: Transfus Med Rev Date: 2007-04

3 in total

Review 1. Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.

2. Plasma-derived medicinal products: demand and clinical use.

Authors: Giuliano Grazzini; Pier Mannuccio Mannucci; Fabrizio Oleari
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

Review 3. The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative.

Authors: Albert Farrugia; Giuliano Grazzini; Isabella Quinti; Fabio Candura; Samantha Profili; Giancarlo M Liumbruno
Journal: Blood Transfus Date: 2019-12-11 Impact factor: 3.443

3 in total